Journal
WIENER MEDIZINISCHE WOCHENSCHRIFT
Volume 159, Issue 9-10, Pages 230-234Publisher
SPRINGER WIEN
DOI: 10.1007/s10354-009-0647-y
Keywords
Osteoporosis; bone remodeling; osteoblasts; osteoclasts; osteoimmunology; pig
Categories
Funding
- Amgen GmbH
- Eli Lilly GmbH
- MSD Merck Sharp Dohme GesmbH
- Nycomed Pharma
- Roche Austria
- Servier Austria
- Sanofi Aventis
Ask authors/readers for more resources
Osteoporosis is a classical age-related disease that affects women more often than men. The hypothesis that osteoporosis is a consequence of estrogen deficiency, has been proposed as early as 1941 by Albright and colleagues [1]. The exact mechanisms of this steroid hormone deficiency in postmenopausal women as well as in the elderly men are continuously being unraveled. Collectively, estrogen deficiency has direct as well as indirect impacts on bone metabolism all of which promote osteoclastogenesis. This review aims at shedding light on the endocrine and osteoimmunological mechanisms that lead to involutional osteoporosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available